PubRank

Michael B Cohen

Author PubWeight™ 67.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Implementation of virtual microscope slides in the annual pathobiology of cancer workshop laboratory. Hum Pathol 2003 2.01
2 Pathologist workforce in the United States: I. Development of a predictive model to examine factors influencing supply. Arch Pathol Lab Med 2013 1.78
3 An inducible model of abacterial prostatitis induces antigen specific inflammatory and proliferative changes in the murine prostate. Prostate 2011 1.68
4 Aberration in the expression of the retinoid receptor, RXRalpha, in prostate cancer. Cancer Biol Ther 2003 1.58
5 Trichostatin A (TSA) sensitizes the human prostatic cancer cell line DU145 to death receptor ligands treatment. Cancer Biol Ther 2005 1.54
6 MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer. Cancer Biol Ther 2008 1.48
7 TRAIL-DISC formation is androgen-dependent in the human prostatic carcinoma cell line LNCaP. Cancer Biol Ther 2003 1.47
8 Coauthorship in pathology, a comparison with physics and a survery-generated and member-preferred authorship guideline. MedGenMed 2004 1.45
9 Bisindolylmaleimide IX Induces Reversible and Time-Dependent Tumor Necrosis Factor Receptor Family-Mediated Caspase Activation and Cell Death. Cancer Biol Ther 2003 1.40
10 Commentary: Mentoring the mentor: executive coaching for clinical departmental executive officers. Acad Med 2010 1.38
11 Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry. Prostate 2002 1.32
12 Mandatory second opinion in surgical pathology referral material: clinical consequences of major disagreements. Am J Surg Pathol 2008 1.14
13 Androgen regulates apoptosis induced by TNFR family ligands via multiple signaling pathways in LNCaP. Oncogene 2005 1.12
14 Cooperation of two mutant p53 alleles contributes to Fas resistance of prostate carcinoma cells. Cancer Res 2003 1.10
15 Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis. Cancer Res 2006 1.09
16 Achieving successful deployment of Bt rice. Trends Plant Sci 2004 1.06
17 Letters to the editor. Endocr Pract 2015 1.06
18 Baby shampoo nasal irrigations for the symptomatic post-functional endoscopic sinus surgery patient. Am J Rhinol 2008 1.06
19 Chemotherapeutic agents up-regulate the cytomegalovirus promoter: implications for bioluminescence imaging of tumor response to therapy. Cancer Res 2007 1.05
20 Death receptor-induced cell death in prostate cancer. J Cell Biochem 2004 1.05
21 Calcium/calmodulin-dependent kinase II plays an important role in prostate cancer cell survival. Cancer Biol Ther 2007 1.04
22 Runx2 regulates survivin expression in prostate cancer cells. Lab Invest 2009 1.03
23 Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor alpha allele in the prostate epithelium. Cancer Res 2002 1.02
24 Impact of small fitness costs on pest adaptation to crop varieties with multiple toxins: a heuristic model. J Econ Entomol 2006 1.02
25 Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor-positive prostate cancer cells. Mol Cancer Res 2006 1.02
26 Mouse prostate cancer cell lines established from primary and postcastration recurrent tumors. Horm Cancer 2010 1.01
27 Slow disease progression in a C57BL/6 pten-deficient mouse model of prostate cancer. Am J Pathol 2011 1.01
28 T-cell recognition of a prostate specific antigen is not sufficient to induce prostate tissue destruction. Prostate 2006 1.00
29 Effects of Bacillus thuringiensis on non-target herbivore and natural enemy assemblages in tropical irrigated rice. Environ Biosafety Res 2004 1.00
30 p53 Is required for 1,25-dihydroxyvitamin D3-induced G0 arrest but is not required for G1 accumulation or apoptosis of LNCaP prostate cancer cells. Endocrinology 2003 1.00
31 Caspase-8 activation is necessary but not sufficient for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in the prostatic carcinoma cell line LNCaP. Prostate 2002 0.94
32 Fibroblast growth factor 8 isoform B overexpression in prostate epithelium: a new mouse model for prostatic intraepithelial neoplasia. Cancer Res 2002 0.93
33 Bacillus thuringiensis delta-endotoxin binding to brush border membrane vesicles of rice stem borers. Arch Insect Biochem Physiol 2004 0.91
34 Ddb2 is a haploinsufficient tumor suppressor and controls spontaneous germ cell apoptosis. Hum Mol Genet 2007 0.90
35 Contribution of death receptor and mitochondrial pathways to Fas-mediated apoptosis in the prostatic carcinoma cell line PC3. Prostate 2002 0.89
36 Pathology education: quo vadis? Hum Pathol 2008 0.89
37 TSA-induced cell death in prostate cancer cell lines is caspase-2 dependent and involves the PIDDosome. Cancer Biol Ther 2006 0.88
38 An enhanced antigen-retrieval protocol for immunohistochemical staining of formalin-fixed, paraffin-embedded tissues. Methods Mol Biol 2011 0.87
39 Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer. J Biol Chem 2012 0.86
40 Effects of an LL-37-derived antimicrobial peptide in an animal model of biofilm Pseudomonas sinusitis. Am J Rhinol Allergy 2009 0.86
41 Bisindolylmaleimide IX facilitates tumor necrosis factor receptor family-mediated cell death and acts as an inhibitor of transcription. J Biol Chem 2002 0.85
42 Inhibition of p53 expression modifies the specificity of chromatin binding by the androgen receptor. Oncotarget 2012 0.85
43 KN-93 inhibits androgen receptor activity and induces cell death irrespective of p53 and Akt status in prostate cancer. Cancer Biol Ther 2010 0.85
44 Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L). Breast Cancer Res Treat 2007 0.85
45 Overexpression of BAD potentiates sensitivity to tumor necrosis factor-related apoptosis-inducing ligand treatment in the prostatic carcinoma cell line LNCaP. Mol Cancer Res 2003 0.84
46 TOFA (5-tetradecyl-oxy-2-furoic acid) reduces fatty acid synthesis, inhibits expression of AR, neuropilin-1 and Mcl-1 and kills prostate cancer cells independent of p53 status. Cancer Biol Ther 2011 0.83
47 Cytologic diagnosis of adenocarcinoma in biliary and pancreatic duct brushings. Adv Anat Pathol 2002 0.83
48 Assessing implicit gender bias in Medical Student Performance Evaluations. Eval Health Prof 2010 0.83
49 Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1α-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pin. Prostate 2013 0.83
50 Loss of survivin in the prostate epithelium impedes carcinogenesis in a mouse model of prostate adenocarcinoma. PLoS One 2013 0.82
51 Multiple effects of N-alpha-tosyl-L-phenylalanyl chloromethyl ketone (TPCK) on apoptotic pathways in human prostatic carcinoma cell lines. Cancer Biol Ther 2004 0.82
52 Expression of prostate specific antigen (PSA) is negatively regulated by p53. Oncogene 2002 0.82
53 Tumor necrosis factor-related apoptosis-inducing ligand-mediated activation of mitochondria-associated nuclear factor-kappaB in prostatic carcinoma cell lines. Mol Cancer Res 2004 0.82
54 Evaluating prostate cancer cell culturing methods: a comparison of cell morphologies and metabolic activity. Oncol Rep 2003 0.81
55 Dystroglycan is not required for maintenance of the luminal epithelial basement membrane or cell polarity in the mouse prostate. Prostate 2010 0.80
56 Updated protocol for the examination of specimens from patients with carcinoma of the urinary bladder, ureter, and renal pelvis. Arch Pathol Lab Med 2003 0.80
57 A preliminary diagnosis service provides prospective blinded dual-review of all general surgical pathology cases in an academic practice. Am J Surg Pathol 2005 0.79
58 Nondestructive near-infrared spectroscopic measurement of multiple analytes in undiluted samples of serum-based cell culture media. Biotechnol Bioeng 2002 0.79
59 Mandatory second opinion in cytopathology. Cancer 2009 0.79
60 Contextual effect of repression of bone morphogenetic protein activity in prostate cancer. Endocr Relat Cancer 2013 0.79
61 Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma. Liver Transpl 2008 0.79
62 Dependence of castration-resistant prostate cancer (CRPC) stem cells on CRPC-associated fibroblasts. J Cell Physiol 2014 0.79
63 Prostate cancer-specific monoclonal antibody 5D4 significantly enhances the cytotoxicity of doxorubicin-loaded liposomes against target cells in vitro. J Drug Target 2008 0.78
64 FISHing and beyond in urinary cytology. Diagn Cytopathol 2004 0.77
65 Clinical correlation between irrigation bottle contamination and clinical outcomes in post-functional endoscopic sinus surgery patients. Am J Rhinol Allergy 2009 0.76
66 Tumor progression and metastasis from genetic to microenvironmental determinants: a workshop of the tumor progression and metastasis NIH study section in honor of Dr. Martin L. Padarathsingh, May 31, 2006, Georgetown, Washington, DC. Cancer Biol Ther 2006 0.76
67 P53 and the proteasome regulate androgen receptor activity. Cancer Biol Ther 2012 0.76
68 Improving Pap test turnaround time using external benchmark data and engineering process improvement tools. Am J Clin Pathol 2002 0.76
69 On the chemoprevention TRAIL. Cancer Biol Ther 2002 0.75
70 Ecthyma gangrenosum mimicking acute invasive fungal sinusitis in an immunocompromised patient. Ear Nose Throat J 2010 0.75
71 The master diagnostic anatomic pathologist. Arch Pathol Lab Med 2015 0.75
72 A Web-based database for pathology faculty effort reporting. Hum Pathol 2008 0.75
73 On-line monitoring of human prostate cancer cells in a perfusion rotating wall vessel by near-infrared spectroscopy. Biotechnol Bioeng 2004 0.75
74 It's Our Turn: Implications for Pathology From the Institute of Medicine's Report on Diagnostic Error. Arch Pathol Lab Med 2016 0.75
75 Pathology and the humanities. Hum Pathol 2008 0.75
76 Small peripheral pulmonary adenocarcinoma: morphologic and molecular update. Adv Anat Pathol 2007 0.75
77 Verification and classification bias interactions in diagnostic test accuracy studies for fine-needle aspiration biopsy. Cancer Cytopathol 2014 0.75
78 Giant cell tumor of bone presenting in the lumbar spine of a 35-year-old female: cytodiagnosis and other diagnostic considerations. Diagn Cytopathol 2013 0.75
79 The Pathologist Workforce in the United States: II. An Interactive Modeling Tool for Analyzing Future Qualitative and Quantitative Staffing Demands for Services. Arch Pathol Lab Med 2015 0.75